Extracorporeal membrane oxygenation for chickenpox pneumonia: A single institution's experience

Ralph W. White, Giles J. Peek, David R. Jenkins, Hilliary M. Killer, Richard K. Firmin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The experience of extracorporeal membrane oxygenation (ECMO) use for severe chickenpox pneumonia was reviewed. Case notes of all patients treated with ECMO for this disease between 1992 and 1997 were reviewed. Of 405 patients referred for ECMO during this period, the diagnosis was chickenpox pneumonia in 14 (3.5%); all 14 were treated with ECMO. The median age of patients was 32.5 years (range 5 to 61 years). The median duration of extracorporeal support was 164 hours (range 45 to 652). Ten of 14 patients (71%) required hemofiltration. Overall survival of patients supported with ECMO was 57% (8 of 14). Deaths were caused by sepsis (5 patients, source identified in 4) and multiorgan failure (1 patient). Pneumonia as a complication of chickenpox can rapidly become severe and life threatening. Extracorporeal respiratory support may be helpful in patients refractory to conventional ventilation.

Original languageEnglish (US)
Pages (from-to)378-382
Number of pages5
JournalASAIO Journal
Volume49
Issue number4
StatePublished - Jul 2003
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Oxygenation
Chickenpox
Pneumonia
Membranes
Refractory materials
Ventilation
Hemofiltration
Sepsis
Survival

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

White, R. W., Peek, G. J., Jenkins, D. R., Killer, H. M., & Firmin, R. K. (2003). Extracorporeal membrane oxygenation for chickenpox pneumonia: A single institution's experience. ASAIO Journal, 49(4), 378-382.

Extracorporeal membrane oxygenation for chickenpox pneumonia : A single institution's experience. / White, Ralph W.; Peek, Giles J.; Jenkins, David R.; Killer, Hilliary M.; Firmin, Richard K.

In: ASAIO Journal, Vol. 49, No. 4, 07.2003, p. 378-382.

Research output: Contribution to journalArticle

White, RW, Peek, GJ, Jenkins, DR, Killer, HM & Firmin, RK 2003, 'Extracorporeal membrane oxygenation for chickenpox pneumonia: A single institution's experience', ASAIO Journal, vol. 49, no. 4, pp. 378-382.
White RW, Peek GJ, Jenkins DR, Killer HM, Firmin RK. Extracorporeal membrane oxygenation for chickenpox pneumonia: A single institution's experience. ASAIO Journal. 2003 Jul;49(4):378-382.
White, Ralph W. ; Peek, Giles J. ; Jenkins, David R. ; Killer, Hilliary M. ; Firmin, Richard K. / Extracorporeal membrane oxygenation for chickenpox pneumonia : A single institution's experience. In: ASAIO Journal. 2003 ; Vol. 49, No. 4. pp. 378-382.
@article{b312775de4b047c794dc573891e3f825,
title = "Extracorporeal membrane oxygenation for chickenpox pneumonia: A single institution's experience",
abstract = "The experience of extracorporeal membrane oxygenation (ECMO) use for severe chickenpox pneumonia was reviewed. Case notes of all patients treated with ECMO for this disease between 1992 and 1997 were reviewed. Of 405 patients referred for ECMO during this period, the diagnosis was chickenpox pneumonia in 14 (3.5{\%}); all 14 were treated with ECMO. The median age of patients was 32.5 years (range 5 to 61 years). The median duration of extracorporeal support was 164 hours (range 45 to 652). Ten of 14 patients (71{\%}) required hemofiltration. Overall survival of patients supported with ECMO was 57{\%} (8 of 14). Deaths were caused by sepsis (5 patients, source identified in 4) and multiorgan failure (1 patient). Pneumonia as a complication of chickenpox can rapidly become severe and life threatening. Extracorporeal respiratory support may be helpful in patients refractory to conventional ventilation.",
author = "White, {Ralph W.} and Peek, {Giles J.} and Jenkins, {David R.} and Killer, {Hilliary M.} and Firmin, {Richard K.}",
year = "2003",
month = "7",
language = "English (US)",
volume = "49",
pages = "378--382",
journal = "ASAIO journal (American Society for Artificial Internal Organs : 1992)",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenation for chickenpox pneumonia

T2 - A single institution's experience

AU - White, Ralph W.

AU - Peek, Giles J.

AU - Jenkins, David R.

AU - Killer, Hilliary M.

AU - Firmin, Richard K.

PY - 2003/7

Y1 - 2003/7

N2 - The experience of extracorporeal membrane oxygenation (ECMO) use for severe chickenpox pneumonia was reviewed. Case notes of all patients treated with ECMO for this disease between 1992 and 1997 were reviewed. Of 405 patients referred for ECMO during this period, the diagnosis was chickenpox pneumonia in 14 (3.5%); all 14 were treated with ECMO. The median age of patients was 32.5 years (range 5 to 61 years). The median duration of extracorporeal support was 164 hours (range 45 to 652). Ten of 14 patients (71%) required hemofiltration. Overall survival of patients supported with ECMO was 57% (8 of 14). Deaths were caused by sepsis (5 patients, source identified in 4) and multiorgan failure (1 patient). Pneumonia as a complication of chickenpox can rapidly become severe and life threatening. Extracorporeal respiratory support may be helpful in patients refractory to conventional ventilation.

AB - The experience of extracorporeal membrane oxygenation (ECMO) use for severe chickenpox pneumonia was reviewed. Case notes of all patients treated with ECMO for this disease between 1992 and 1997 were reviewed. Of 405 patients referred for ECMO during this period, the diagnosis was chickenpox pneumonia in 14 (3.5%); all 14 were treated with ECMO. The median age of patients was 32.5 years (range 5 to 61 years). The median duration of extracorporeal support was 164 hours (range 45 to 652). Ten of 14 patients (71%) required hemofiltration. Overall survival of patients supported with ECMO was 57% (8 of 14). Deaths were caused by sepsis (5 patients, source identified in 4) and multiorgan failure (1 patient). Pneumonia as a complication of chickenpox can rapidly become severe and life threatening. Extracorporeal respiratory support may be helpful in patients refractory to conventional ventilation.

UR - http://www.scopus.com/inward/record.url?scp=0042308606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042308606&partnerID=8YFLogxK

M3 - Article

C2 - 12918577

AN - SCOPUS:0042308606

VL - 49

SP - 378

EP - 382

JO - ASAIO journal (American Society for Artificial Internal Organs : 1992)

JF - ASAIO journal (American Society for Artificial Internal Organs : 1992)

SN - 1058-2916

IS - 4

ER -